Drug intelligence / Profile preview

flax lignan

Development stage
Unknown
Lead developer
Archer Daniels Midland
Modality
Small Molecules
Administration
Oral
01

Overview

Flax lignan refers primarily to the class of plant-derived polyphenolic compounds known as lignans found in high concentrations in flaxseed. The principal and most studied flaxseed lignan is secoisolariciresinol diglucoside (SDG). Lignans are phytoestrogens—plant compounds structurally similar to estrogen—that can exert weak estrogenic or anti-estrogenic effects in the body. After ingestion, SDG is converted by intestinal microflora into enterolignans (enterodiol and enterolactone), which may have biological activity. Mechanistically, flax lignans are thought to modulate estrogen metabolism by promoting the production of less active estrogen metabolites. This may contribute to potential benefits for hormone-related conditions such as menopausal symptoms and breast cancer risk reduction[8][7]. Flaxseed consumption has also been associated with improvements in cholesterol levels, blood pressure, renal function (especially in lupus nephritis), and markers of inflammation[1][2][5][8]. Some studies suggest anti-inflammatory and antioxidant properties for SDG[10].

Brand names
BeneFlaxBrevail
Other names
secoisolariciresinol diglucosideSDGflaxseed lignanplant lignan
02

Targets

ER (Estrogen receptor)TLR4 (Toll-like receptor 4)CYP19A1 (Aromatase)

Beyond the preview

Go deeper on flax lignan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on flax lignan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call